Pulmonary perfusion with L-arginine ameliorates post-cardiopulmonary bypass lung injury in a rabbit model

Journal of Surgical Research

Volumn 167, Issue 2, 2011, Pages

  Chao, Yin Kai ^a,b   Wu, Yi Cheng ^a   Yang, Kun Ju ^c   Chiang, Ling Ling ^d   Liu, Hui Ping ^b   Lin, Pyng Jing ^b   Chu, Yen ^b  

^a Graduate Institute of Clinical Medical Sciences   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

inflammatory cytokine; L arginine; post CPB lung injury; pulmonary perfusion

Indexed keywords

ARGININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOTHELIUM INJURY; ENZYME ACTIVITY; FEMALE; ISCHEMIA; LUNG ENDOTHELIUM; LUNG FUNCTION; LUNG INJURY; LUNG PARENCHYMA; LUNG PERFUSION; LUNG VASCULAR RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY; STERNOTOMY;

ACUTE LUNG INJURY; ANIMALS; ARGININE; CARDIOPULMONARY BYPASS; INTERLEUKIN-1BETA; LUNG; MODELS, ANIMAL; NF-KAPPA B; PERFUSION; PEROXIDASE; PULMONARY ARTERY; RABBITS; REPERFUSION INJURY; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR RESISTANCE; VASODILATION;

EID: 79954604756     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.10.041     Document Type: Article

References (22)

1. C.S. Ng, S. Wan, A.P. Yim, and A.A. Arifi Pulmonary dysfunction after cardiac surgery Chest 121 2002 1269
2. P. Massoudy, S. Zahler, and B.F. Becker Evidence for inflammatory responses of the lungs during coronary artery bypass grafting with cardiopulmonary bypass Chest 119 2001 31
3. J.M. Dodd-o, L.E. Welsh, and J.D. Salazar Effect of bronchial artery blood flow on cardiopulmonary bypass-induced lung injury Am J Physiol Heart Circ Physiol 286 2004 H693
4. C. Schlensak, T. Doenst, and S. Preusser Cardiopulmonary bypass reduction of bronchial blood flow: A potential mechanism for lung injury in a neonatal pig model J Thorac Cardiovasc Surg 123 2002 1199
5. C. Schlensak, T. Doenst, and S. Preusser Bronchial artery perfusion during cardiopulmonary bypass does not prevent ischemia of the lung in piglets: Assessment of bronchial artery blood flow with fluorescent microspheres Eur J Cardiothorac Surg 19 2001 326 discussion 331
6. K. Morita, K. Ihnken, and G.D. Buckberg Pulmonary vasoconstriction due to impaired nitric oxide production after cardiopulmonary bypass Ann Thorac Surg 61 1996 1775
7. B. Wei, Y. Liu, and Q. Wang Lung perfusion with protective solution relieves lung injury in corrections of Tetralogy of Fallot Ann Thorac Surg 77 2004 918
8. T. Suzuki, T. Ito, and I. Kashima Continuous perfusion of pulmonary arteries during total cardiopulmonary bypass favorably affects levels of circulating adhesion molecules and lung function J Thorac Cardiovasc Surg 122 2001 242
9. T. Suzuki, T. Fukuda, and T. Ito Continuous pulmonary perfusion during cardiopulmonary bypass prevents lung injury in infants Ann Thorac Surg 69 2000 602
10. M. Siepe, U. Goebel, and A. Mecklenburg Pulsatile pulmonary perfusion during cardiopulmonary bypass reduces the pulmonary inflammatory response Ann Thorac Surg 86 2008 115
11. Y. Yang, Z. Su, and J. Cai Continuous pulmonary infusion of l-arginine during deep hypothermia and circulatory arrest improves pulmonary surfactant integrity in piglets Ann Thorac Surg 86 2008 429 discussion 435
12. M. Angdin, G. Settergren, and J. Liska No effect of l-arginine supplementation on pulmonary endothelial dysfunction after cardiopulmonary bypass Acta Anaesthesiol Scand 45 2001 441
13. J.C. Fitch, S. Rollins, and L. Matis Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass Circulation 100 1999 2499
14. D. Royston, J.H. Levy, and J. Fitch Full-dose aprotinin use in coronary artery bypass graft surgery: An analysis of perioperative pharmacotherapy and patient outcomes Anesth Analg 103 2006 1082
15. S. Ashraf, Y. Tian, and D. Cowan Release of proinflammatory cytokines during pediatric cardiopulmonary bypass: Heparin-bonded versus nonbonded oxygenators Ann Thorac Surg 64 1997 1790
16. C.M. Calkins, D.D. Bensard, and J.K. Heimbach l-arginine attenuates lipopolysaccharide-induced lung chemokine production Am J Physiol Lung Cell Mol Physiol 280 2001 L400
17. M. Gorenflo, M.V. Ullmann, and K. Eitel Plasma l-arginine and metabolites of nitric oxide synthase in patients with left-to-right shunt after intracardiac repair Chest 127 2005 1184
18. P. Chattopadhyay, N. Verma, and A. Verma l-arginine protects from Pringle maneuver of ischemia-reperfusion induced liver injury Biol Pharm Bull 31 2008 890
19. B. Cao, N. Li, Y. Wang, and J.S. Li Protective effect of l-arginine preconditioning on ischemia and reperfusion injury associated with rat small bowel transplantation World J Gastroenterol 11 2005 2994
20. S.K. Yoon, K.N. Lee, and J.H. Lee Pulmonary vascular dilation induced by l-arginine: Correlation with induction of endothelial nitric oxide synthase in a rabbit model Acta Radiol 46 2005 48
21. H.M. Razavi, F. Wang le, and S. Weicker Pulmonary neutrophil infiltration in murine sepsis: Role of inducible nitric oxide synthase Am J Respir Crit Care Med 170 2004 227
22. K. Hnia, J. Gayraud, and G. Hugon l-arginine decreases inflammation and modulates the nuclear factor-κB/matrix metalloproteinase cascade in mdx muscle fibers Am J Pathol 172 2008 1509